Your browser doesn't support javascript.
loading
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
Dore, Gregory J; Conway, Brian; Luo, Yan; Janczewska, Ewa; Knysz, Brygida; Liu, Yan; Streinu-Cercel, Adrian; Caruntu, Florin Alexandru; Curescu, Manuela; Skoien, Richard; Ghesquiere, Wayne; Mazur, Wlodzimierz; Soza, Alejandro; Fuster, Francisco; Greenbloom, Susan; Motoc, Adriana; Arama, Victoria; Shaw, David; Tornai, Istvan; Sasadeusz, Joseph; Dalgard, Olav; Sullivan, Danielle; Liu, Xuan; Kapoor, Mudra; Campbell, Andrew; Podsadecki, Thomas.
Afiliação
  • Dore GJ; Kirby Institute, UNSW Australia, and St. Vincent's Hospital, Sydney, Australia. Electronic address: gdore@kirby.unsw.edu.au.
  • Conway B; Vancouver Infectious Diseases Centre, Vancouver, Canada.
  • Luo Y; AbbVie Inc., North Chicago, USA.
  • Janczewska E; ID Clinic, Myslowice, Poland.
  • Knysz B; Wroclaw Medical University, Wroclaw, Poland.
  • Liu Y; AbbVie Inc., North Chicago, USA.
  • Streinu-Cercel A; Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases "Prof. Dr. Matei Balș", Bucharest, Romania.
  • Caruntu FA; National Institute for Infectious Diseases "Prof. Dr. Matei Bals", Bucharest, Romania.
  • Curescu M; Clinic of Infectious Diseases, University of Medicine and Pharmacy Timisoara, Timisoara, Romania.
  • Skoien R; Royal Brisbane and Women's Hospital, Brisbane, Australia.
  • Ghesquiere W; Island Health Authority, Section of Infectious Diseases, Victoria, Canada.
  • Mazur W; Clinical Department of Infectious Disease, Medical University of Silesia, Katowice, Poland.
  • Soza A; Department of Gastroenterology, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Fuster F; Centro de Investigaciones Cínicas Viña del Mar, Viña del Mar, Chile.
  • Greenbloom S; Toronto Digestive Disease Associates, Toronto, Canada.
  • Motoc A; Hospital of Infectious Diseases Dr. Victor Babes, Bucharest, Romania.
  • Arama V; Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases "Prof. Dr. Matei Balș", Bucharest, Romania.
  • Shaw D; Royal Adelaide Hospital, Infectious Diseases Department, and University of Adelaide, Adelaide, Australia.
  • Tornai I; University of Debrecen, Department of Medicine, Division of Gastroenterology, Debrecen, Hungary.
  • Sasadeusz J; Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Dalgard O; Akershus University Hospital, Lorenskog, Norway.
  • Sullivan D; AbbVie Inc., North Chicago, USA.
  • Liu X; AbbVie Inc., North Chicago, USA.
  • Kapoor M; AbbVie Inc., North Chicago, USA.
  • Campbell A; AbbVie Inc., North Chicago, USA.
  • Podsadecki T; AbbVie Inc., North Chicago, USA.
J Hepatol ; 64(1): 19-28, 2016 Jan.
Article em En | MEDLINE | ID: mdl-26321288
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Sulfonamidas / Uracila / Carbamatos / Hepacivirus / Hepatite C Crônica / Compostos Macrocíclicos / Anilidas Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Sulfonamidas / Uracila / Carbamatos / Hepacivirus / Hepatite C Crônica / Compostos Macrocíclicos / Anilidas Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2016 Tipo de documento: Article